Elliott Nickbarg

Elliott Nickbarg

Company: Merck & Co

Job title: Principal Scientist


Exploring the Undiscovered Country of RNA Drug Targets: Finding Bioactive Ligands Against Xist RNA with Affinity-Selection MS Screening 2:45 pm

Affinity-selection MS screening can find binders to a wide variety of RNA targets RNA-binding ligands can then be profiled to determine structural features that bias them to bind to RNA targets Biophysical and cell-based techniques have been applied to characterize activities of novel binders to be bacterial and mammalian non-coding RNA targetsRead more

day: Day Two

Panel Discussion – Combining Biochemical, Biophysical & Cell-Based Assay Systems for the Future of RNA Drug Discovery 12:00 pm

Leveraging the learnings to determine the best assays for RNA-targeted drug discovery How to effectively use conventional biophysical methods? How to successfully measure biochemical activity? How to develop novel approaches for cell-based systems?Read more

day: Pre-Conference Focus Day

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.